Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

PHASE3CompletedINTERVENTIONAL

Enrollment

2,665

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2007

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

vildagliptin

vildagliptin as add-on to metformin

DRUG

thiazolidinedione (TZD)

TZD add-on to metformin

Trial Locations (1)

Novartis Pharmaceuticals, East Hanover